H2 Haplotype and CYP3As Polymorphisms and the Antiplatelet Response to Clopidogrel

Clinical trial NCT00433784 · COMPLETED

Trial details

NCT number: NCT00433784
Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Artery Disease Elective Percutaneous Coronary Intervention

Start date: 2004-09-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.